High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis
- 23 September 2011
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 26 (3), 559-562
- https://doi.org/10.1038/leu.2011.266
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Frequent mutation of histone-modifying genes in non-Hodgkin lymphomaNature, 2011
- Acquired TNFRSF14 Mutations in Follicular Lymphoma Are Associated with Worse PrognosisCancer Research, 2010
- Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent TFH–B cell axisLeukemia, 2010
- High resolution analysis of follicular lymphoma genomes reveals somatic recurrent sites of copy‐neutral loss of heterozygosity and copy number alterations that target single genesGenes, Chromosomes and Cancer, 2010
- High Expression of the Inhibitory Receptor BTLA in T-Follicular Helper Cells and in B-Cell Small Lymphocytic Lymphoma/Chronic Lymphocytic LeukemiaAmerican Journal of Clinical Pathology, 2009
- Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalancesBlood, 2009
- Microarray‐based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression statusGenes, Chromosomes and Cancer, 2008
- Attenuating Lymphocyte ActivityPublished by Elsevier BV ,2005
- Stimulation of non-Hodgkin's lymphoma via HVEM: an alternate and safe way to increase Fas-induced apoptosis and improve tumor immunogenicityLeukemia, 2003
- Herpesvirus Entry Mediator Ligand (HVEM-L), a Novel Ligand for HVEM/TR2, Stimulates Proliferation of T Cells and Inhibits HT29 Cell GrowthPublished by Elsevier BV ,1998